Product Reports Resources Pricing Login Book a demo

Vial

Biotech & Life Sciences · San Francisco, United States · Founded 2020

A tech-enabled CRO delivering superior clinical trial outcomes MoreLess

Vial.com is a technology-driven Contract Research Organization (CRO) that operates in the global clinical trials market. Its mission is to empower scientists to cure all human diseases by delivering faster and more efficient trials. The company serves clients in the pharmaceutical and biotechnology sectors, helping them conduct clinical trials more efficiently and at a larger scale.

Vial.com's business model revolves around its proprietary Vial Technology Platform. This platform uses connected systems and intuitive design to streamline the clinical trial process, moving it away from traditional paper-based methods. The platform allows for seamless transitions between different visits and phases of a trial, redefining how these trials are conducted.

The company also offers a fixed-fee pricing model, which helps clients maximize their return on investment (ROI). This means that clients pay a set price for the service, regardless of the time and resources it takes to complete the trial. This model provides cost certainty for clients and incentivizes Vial.com to conduct trials as efficiently as possible.

Vial.com also provides thought leadership in the industry, publishing white papers on topics such as the future landscape of dermatology clinical trials and best practices for patient recruitment in oncology.

In summary, Vial.com is a technology-driven CRO that uses its proprietary platform to conduct clinical trials more efficiently and at a larger scale. It serves clients in the pharmaceutical and biotech sectors and operates on a fixed-fee pricing model.

Keywords: Clinical Trials, Contract Research Organization, Technology-Driven, Pharmaceutical Sector, Biotechnology Sector, Vial Technology Platform, Streamlined Processes, Fixed-Fee Pricing Model, Thought Leadership, Global Market.

Valuation $100–500M
Revenue $10–50M
Headcount 100–500
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Vial and the history behind them.

Talent graph

Vial's talent

Book a demo to see the people
Team profiled 17 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

22 investors on Vial's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Buckley Ventures
Series A 21 investors entered at this stage
Adam Rothenberg
David Tisch
Hemant Taneja
Zak Kukoff
Josh Buckley
Greg R. Meland
TJ Nahigian
Byers Capital
General Catalyst
BoxGroup
Blake Byers
Dan Ashton
JD Ross
Jeff Silverstein
Elena Viboch
Gordon Wintrob
Connor Zwick
Nikhil Krishnan
David Hsu
Nimi Katragadda
Spike Lipkin

Global footprint

Where Vial has talent and traffic

Workforce by country
10 countries with
team presence
🇺🇸 United States44%
🇨🇦 Canada26%
🇦🇺 Australia12%
🇨🇱 Chile4%
🇧🇩 Bangladesh2%
Top 5 of 10 shown

Market sentiment

What the market is saying about Vial

An AI-synthesized read of the highest-engagement posts about Vial on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vial on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.